These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 890179)

  • 41. USP: Congress' alternative solution.
    Owen JA
    Hosp Formul; 1978 Oct; 13(10):801-2, 804. PubMed ID: 10238811
    [No Abstract]   [Full Text] [Related]  

  • 42. Panel discussion: Proposed changes in the USP--Microbiological aspects. II. Biological indicators.
    Artandi C
    Bull Parenter Drug Assoc; 1969; 23(6):254-7. PubMed ID: 4901567
    [No Abstract]   [Full Text] [Related]  

  • 43. [Filtering effectiveness of conventional 15 m micron filters (DIN 58362) and newly developed 15 m micron and 5 m micron filters. I: Particle count].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Infusionstherapie; 1989 Apr; 16(2):77-80. PubMed ID: 2737765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. USP standards process.
    Heller WM
    J Parenter Sci Technol; 1986; 40(1):14-7. PubMed ID: 3701537
    [No Abstract]   [Full Text] [Related]  

  • 45. Relationship of USP-NF to NDA and ANDA "Standards".
    Belson JJ
    Am J Hosp Pharm; 1982 May; 39(5):869-70. PubMed ID: 7081269
    [No Abstract]   [Full Text] [Related]  

  • 46. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 47. Unusual sources of drug information required and utilized by the USP.
    Griffiths MC
    Drug Inf J; 1975; 9(2-3):73-5. PubMed ID: 10236980
    [No Abstract]   [Full Text] [Related]  

  • 48. USP--promoting the public health.
    Carothers N
    Todays Surg Nurse; 1998; 20(1):35-9. PubMed ID: 9866636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy.
    Akers MJ; Schrank GD; Russell S
    Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Particulate matter in cephalosporin injections.
    Mioduch HJ; Czaplicki AD; Schulz BG
    Am J Hosp Pharm; 1983 Nov; 40(11):1982-3. PubMed ID: 6650530
    [No Abstract]   [Full Text] [Related]  

  • 51. The development of USP botanical dietary supplement monographs, 1995-2005.
    Schiff PL; Srinivasan VS; Giancaspro GI; Roll DB; Salguero J; Sharaf MH
    J Nat Prod; 2006 Mar; 69(3):464-72. PubMed ID: 16562859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Request that the USP Committee of Revision reevaluate its position relative to the inclusion of clean room air and microbial limits in the U.S. Pharmacopeia (USP).
    Halperin JA
    J Parenter Sci Technol; 1991; 45(4):168. PubMed ID: 1770407
    [No Abstract]   [Full Text] [Related]  

  • 53. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
    Williams RL; ;
    J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Japanese pharmacopeial perspectives on particle measurement of injections.
    Fujishita O; Sendo T; Otsubo K; Aoyama T
    J Pharm Sci Technol; 1994; 48(3):148-54. PubMed ID: 8069516
    [No Abstract]   [Full Text] [Related]  

  • 55. Panel discussion: proposed changes in the USP--microbiological aspects. I. Proposed changes in the USP sterility test.
    Clapp FL
    Bull Parenter Drug Assoc; 1969; 23(6):252-4. PubMed ID: 4901566
    [No Abstract]   [Full Text] [Related]  

  • 56. Origin, result and measurement of USP "essentially free" inspection for visible contaminating particles.
    Knapp JZ
    PDA J Pharm Sci Technol; 2000; 54(3):218-32. PubMed ID: 10927913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydrodynamics-induced variability in the USP apparatus II dissolution test.
    Baxter JL; Kukura J; Muzzio FJ
    Int J Pharm; 2005 Mar; 292(1-2):17-28. PubMed ID: 15725550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proposed USP microbial limits.
    Agalloco J; Akers J
    J Parenter Sci Technol; 1991; 45(4):168-9. PubMed ID: 1770408
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter: Particulate matter in penicillin G potassium injection.
    Turco SJ; Davis NM; Bhatia R
    Am J Hosp Pharm; 1974 Sep; 31(9):825-6. PubMed ID: 4420020
    [No Abstract]   [Full Text] [Related]  

  • 60. While shopping for an herbal supplement, I noticed that some labels say the supplement is USP verified. What does that mean?
    Mayo Clin Health Lett; 2004 Oct; 22(10):8. PubMed ID: 15609437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.